Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Sell
1,478
-4
-0.3% -$468 0.11% 106
2026
Q1
$178K Sell
1,482
-228
-13% -$26.3K 0.1% 108
2025
Q4
$180K Buy
+1,710
New +$161K 0.11% 103
2024
Q4
Sell
-1,838
Closed -$209K 112
2024
Q3
$209K Buy
1,838
+220
+14% +$26.1K 0.15% 104
2024
Q2
$200K Buy
1,618
+14
+0.9% +$1.8K 0.16% 109
2024
Q1
$212K Buy
+1,604
New +$198K 0.16% 109

Other funds holding MRK

Basepoint Wealth's MRK Position: Q2 2026 in Review

Basepoint Wealth reduced its Merck (MRK) stake by 0.27% in Q2 2026, selling an estimated $468 and leaving 1,478 shares worth $190K. The position accounts for 0.11% of the portfolio, ranked #106.

Basepoint Wealth first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $212K in Q1 2024. 3,837 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Basepoint Wealth held 1,478 shares of Merck worth $190K as of Q2 2026.
  • Basepoint Wealth sold 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.11% of Basepoint Wealth's portfolio in Q2 2026, its #106 holding.
  • Basepoint Wealth first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Basepoint Wealth's Merck position peaked at $212K in Q1 2024.
  • 3,837 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.